The report contains an analysis of the drug control situation worldwide so that Governments are kept aware of existing and potential situations that may endanger the objectives of the international drug control treaties. Divided into four parts, it covers the following topics: drugs and corruption, functioning of the international drug control system, analysis of the world situation and finally, a set of recommendations to Governments, the United Nations and other relevant international and regional organisations. A set of Annexes follow as well.
This report offers one of the most comprehensive insights into global trends in international culture, production, seizure and price of illicit drugs. It examines trends in the world's four major markets: opium and heroin, coca and cocaine, cannabis, and amphetamine-type stimulants. This edition provides an in-depth examination of the link between transnational organized crime and drug trafficking. A detailed statistical appendix on production, prices and consumption completes this book, which gives the reader a comprehensive picture of the world's drug problem.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Illicit drug supply and demand are inextricably linked components of a single phenomenon. Contents of this 2007 report by the International Narcotics Control Board: (I) The Principle of Proportionality and Drug-Related Offenses; (II) Operation of the International Drug Control System; (III) Analysis of the World Situation; (IV) Recommendations to Governments, the United Nations and Other Relevant and Regional Organizations. Annexes: (I) Regional Groupings Used in the Report of the International Narcotics Control Board; (II) Current Membership of the International Narcotics Control Board.
Illicit drug supply and demand are inextricably linked components of a single phenomenon. Contents of this 2007 report by the International Narcotics Control Board (INCB): (1) The International Drug Control Conventions: History, Achievements and Challenges; (2) Operation of the International Drug Control System; (3) Analysis of the World Situation; (4) Recommendations to Governments, the United Nations and Other Relevant International and Regional Organizations. Annexes: (1) Regional Groupings Used in the Report of the INCB for 2008; (2) Current Membership of the INCB.
Illegal psychoactive substances and illicit prescription drugs are currently used on a daily basis all over the world. Affecting public health and social welfare, illicit drug use is linked to disease, disability, and social problems. Faced with an increase in usage, national and global policymakers are turning to addiction science for guidance on how to create evidence-based drug policy. Drug Policy and the Public Good is an objective analytical basis on which to build global drug policies. It presents the accumulated scientific knowledge on drug use in relation to policy development on a national and international level. By also revealing new epidemiological data on the global dimensions of drug misuse, it questions existing regulations and highlights the growing need for evidence-based, realistic, and coordinated drug policy. A critical review of cumulative scientific evidence, Drug Policy and the Public Good discusses four areas of drug policy; primary prevention programs in schools and other settings; supply reduction programs, including legal enforcement and drug interdiction; treatment interventions and harm reduction approaches; and control of the legal market through prescription drug regimes. In addition, it analyses the current state of global drug policy, and advocates improvements in the drafting of public health policy. Drug Policy and the Public Good is a global source of information and inspiration for policymakers involved in public health and social welfare. Presenting new research on illicit and prescription drug use, it is also an essential tool for academics, and a significant contribution to the translation of addiction research into effective drug policy.
The three UN drug conventions comprehensively and almost universally regulate the dealing with illicit drugs worldwide. Although the treaties are prohibitive, more and more member states seek to liberalise their national drug policies and implement depenalisation, decriminalisation or even legalisation schemes. The article explores member states’ possibilities and limitations under the current treaty framework by giving an overview of their obligations, contractual exceptions and means under general public international law.
With support from the Open Society Institute International Palliative Care Initiative, Human Rights Watch released a groundbreaking report on the lack of access to pain relief medicines for millions of patients worldwide. The report, "Please Don't Make Us Suffer Anymore": Access to Pain Treatment as a Human Right, finds that countries can significantly improve access to pain medications by addressing the causes of their poor availability, which include the following: *Failure to put in place functioning supply and distribution systems *Absence of government policies to ensure medicine availability *Insufficient instruction for health care workers *Excessively strict drug-control regulations *Fear of legal sanctions among healthcare workers. "Please Don't Make Us Suffer Anymore" notes that international law requires states to make narcotic drugs available for the treatment of pain while preventing abuse, but that the strong international focus on preventing abuse of such drugs has led many countries to neglect that obligation. The full report is available in PDF format. French, Russian, and Spanish versions are available on the HRW website.
There remains substantial agreement among the international community on many aspects of the contemporary UN drug control regime. However, diverging views on the non-medical and non-scientific use of a range of controlled substances make drug policy an increasingly contested and transitionary field of multinational cooperation. Employing a fine-grained and interdisciplinary approach, this book provides the first integrated analysis of the sources, manifestations and sometimes paradoxical implications of this divergence. The author develops an original explanatory framework through which to understand better the dynamic and tense intersection between policy shifts at varying levels of governance and the regime's core prohibitive norm. Highlighting the centrality of the harm reduction approach and tolerant cannabis policies to an ongoing process of regime transformation, this book examines the efforts of those actors seeking to defend the existing international control framework and explores rationales and scenarios which may lead to the international community moving beyond it.
